Medicine Man Technologies Inc Revenue Growth Rates (MDCL), Current and Historic Growth - CSIMarket
CSIMarket
 


Medicine Man Technologies inc   (MDCL)
    Sector • Services    Industry • Consulting Services
   Industry • Consulting Services
   Sector • Services
 

MDCL's Revenue Growth by Quarter and Year

Medicine Man Technologies Inc 's Revenue results by quarter and year




MDCL Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
4th Quarter December 43.32
3rd Quarter September 51.26
2nd Quarter June 41.52
1st Quarter March 39.03
FY 175.13

MDCLs Annual Revenue
Medicine Man Technologies Inc 's Revenue in the fiscal year 2023 $ 172.02 millions
Medicine Man Technologies Inc 's Revenue in the fiscal year 2022 $ 159.03 millions
Medicine Man Technologies Inc 's Revenue in the fiscal year 2021 $ 123.72 millions
Medicine Man Technologies Inc 's Revenue in the fiscal year 2020 $ 24.00 millions
Medicine Man Technologies Inc 's Revenue in the fiscal year 2019 $ 12.40 millions




MDCL Revenue fourth quarter 2023 Y/Y Growth Comment
Medicine Man Technologies inc reported Revenue growth of 7.91% year on year in the fourth quarter 2023, to $ 43.32 millions, this is lower than Medicine Man Technologies Inc 's recent average Revenue surge of 196.52%.

Looking into fourth quarter 2023 results within Consulting Services industry 17 other companies have achieved higher Revenue growth. While Medicine Man Technologies Inc ' s Revenue increase of 7.91% ranks overall at the positon no. 1774 in the fourth quarter 2023.




MDCL Revenue ( Y/Y Growth %) 2023
2022 2021 2020
4th Quarter December 7.91 % -1.13 % 411.46 % 140.61 %
3rd Quarter September 19.32 % 33.67 % 296.3 % 51.87 %
2nd Quarter June -5.98 % 35.5 % 541.54 % 188.64 %
1st Quarter March 26.15 % 68.34 % 317.73 % 120 %
FY   10.7 % 27.88 % 384.61 % -

Financial Statements
Medicine Man Technologies Inc 's fourth quarter 2023 Revenue $ 43.32 millions MDCL's Income Statement
Medicine Man Technologies Inc 's fourth quarter 2022 Revenue $ 40.15 millions Quarterly MDCL's Income Statement


MDCL Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
4th Quarter December -15.48 % -6.54 % 26.35 % -2.1 %
3rd Quarter September 23.46 % -2.72 % -1.38 % 59.65 %
2nd Quarter June 6.38 % 42.73 % 77.31 % 15.45 %
1st Quarter March -2.79 % -23.81 % 131.49 % 33.33 %
FY (Year on Year)   10.7 % 27.88 % 384.61 % -




Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Consulting Services Industry #18
Services Sector #278
Overall #1774

Revenue Y/Y Growth Statistics
High Average Low
2488.57 % 196.52 % -80.64 %
(Mar 31 2023)   (Dec 31 2023)
Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Consulting Services Industry #18
Services Sector #278
Overall #1774
Revenue Y/Y Growth Statistics
High Average Low
2488.57 % 196.52 % -80.64 %
(Mar 31 2023)   (Dec 31 2023)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Medicine Man Technologies Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
82.93 % 16.01 % -50.34 %
(Dec 31 2022)  


MDCL's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2023 Medicine Man Technologies Inc disclosed fall in Revenue from the third quarter by -15.48% to $ 43.32 millions, from $ 51.26 millions achived in the previous reporting period.

But that's not important problem, as Medicine Man Technologies Inc 's Revenue generally seem to plunge in this quarter.

Within Consulting Services industry 3 other companies have achieved higher Revenue quarter on quarter growth. While Medicine Man Technologies Inc 's Revenue growth quarter on quarter, overall rank is 736.


Revenue Q/Q Growth Company Ranking
Within: No.
Consulting Services Industry #4
Services Sector #74
Overall #736
Revenue Q/Q Growth Company Ranking
Within: No.
Consulting Services Industry #4
Services Sector #74
Overall #736
Revenue Q/Q Growth Statistics
High Average Low
82.93 % 16.01 % -50.34 %
(Dec 31 2022)  


MDCL's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2023 Medicine Man Technologies Inc disclosed fall in Revenue from the third quarter by -15.48% to $ 43.32 millions, from $ 51.26 millions achived in the previous reporting period.

But that's not important problem, as Medicine Man Technologies Inc 's Revenue generally seem to plunge in this quarter.

Within Consulting Services industry 3 other companies have achieved higher Revenue quarter on quarter growth. While Medicine Man Technologies Inc 's Revenue growth quarter on quarter, overall rank is 736.


Medicine Man Technologies Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Revenue 12 Months Ending $ 175.14 $ 171.96 $ 163.66 $ 166.30 $ 158.21
Y / Y Revenue Growth (TTM) 10.7 % 8.38 % 10.7 % 22.03 % 27.87 %
Year on Year Revenue Growth Overall Ranking # 12 # 76 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 1.85 % 5.07 % -1.59 % 5.12 % -0.29 %
Seq. Revenue Growth (TTM) Overall Ranking # 331 # 7 # 34 # 20 # 62


Cumulative Revenue growth Comment
Although Medicine Man Technologies Inc 's Annual Revenue growth year on year were below company's average 688.03% , Revenue announced in the Dec 31 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 10.7% year on year, from 8.38% in Sep 30 2023.

Medicine Man Technologies inc achieved highest trailing twelve month year on year Revenue growth. While Total ranking has impoved so far to 12, from total ranking in previous quarter at 76.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Consulting Services Industry # 3
Services Sector # 1
Overall # 12

Revenue TTM Y/Y Growth Statistics
High Average Low
2110.64 %
688.03 %
68.28 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 54
S&P 500 # 331
Cumulative Revenue growth Comment
Although Medicine Man Technologies Inc 's Annual Revenue growth year on year were below company's average 688.03% , Revenue announced in the Dec 31 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 10.7% year on year, from 8.38% in Sep 30 2023.

Medicine Man Technologies inc achieved highest trailing twelve month year on year Revenue growth. While Total ranking has impoved so far to 12, from total ranking in previous quarter at 76.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Consulting Services Industry # 3
Services Sector # 1
Overall # 12

Revenue TTM Y/Y Growth Statistics
High Average Low
2110.64 %
688.03 %
68.28 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 54
S&P 500 # 331




Other Revenue Growth
Consulting Services Industry Revenue Growth Trends and Statistics
Services Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
MDCL's Revenue Growth Ratio versus Consulting Services Industry, Services Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Dec 31 2023 within Services SectorY/Y Change %Revenue for the quarter ending Dec 31 2023
Terreno Realty Corporation13.78%$ 13.784 millions
Roku Inc 13.56%$ 13.559 millions
Galaxy Gaming Inc 13.41%$ 13.413 millions
Verra Mobility Corporation13.41%$ 13.405 millions
Madison Square Garden Entertainment Corp 13.15%$ 13.147 millions
Zhihu Inc 13.14%$ 13.144 millions
United Rentals Inc 13.11%$ 13.107 millions
Spotify Technology S a 12.96%$ 12.962 millions
Enviri Corp12.92%$ 12.922 millions
Booz Allen Hamilton Holding Corporation12.86%$ 12.855 millions
Mastercard Incorporated12.57%$ 12.567 millions
Fangdd Network Group Ltd12.55%$ 12.552 millions
Netflix Inc 12.49%$ 12.491 millions
Green Giant Inc 12.38%$ 12.385 millions
Innovative Industrial Properties Inc 12.34%$ 12.340 millions
Priority Technology Holdings Inc 12.24%$ 12.235 millions
Strategic Education Inc 12.14%$ 12.138 millions
Advanced Oxygen Technologies Inc 11.93%$ 11.927 millions
Chuy s Holdings Inc 11.76%$ 11.764 millions
Lincoln Educational Services Corporation11.71%$ 11.707 millions
Costar Group Inc 11.66%$ 11.665 millions
Calibercos Inc 11.54%$ 11.543 millions
Mobile Infrastructure Corp11.48%$ 11.485 millions
Cra International inc 11.48%$ 11.476 millions
Amc Entertainment Holdings Inc 11.45%$ 11.454 millions
New England Realty Associates Limited Partnership11.43%$ 11.433 millions
Performant Healthcare Inc 11.37%$ 11.371 millions
International Money Express Inc 11.23%$ 11.232 millions
Manchester United Plc11.18%$ 11.180 millions
Maui Land and Pineapple Co Inc11.18%$ 11.178 millions


About Medicine Man Technologies Inc Revenue Growth Rates (MDCL), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Medicine Man Technologies Inc (CIK 1622879).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001558370-24-004104
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Medicine Man Technologies Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.